Stocks of Statera Biopharma Inc. (STAB) are poised to climb above their peers

Statera Biopharma Inc. (NASDAQ: STAB) stock jumped 6.45% on Wednesday to $0.10 against a previous-day closing price of $0.10. With 3.92 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.07 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.1140 whereas the lowest price it dropped to was $0.0970. The 52-week range on STAB shows that it touched its highest point at $3.60 and its lowest point at $0.09 during that stretch. Beta for the stock currently stands at 1.00.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of STAB was up-trending over the past week, with a rise of 2.97%, but this was down by -25.55% over a month. Three-month performance dropped to -51.63% while six-month performance fell -54.76%. The stock lost -96.98% in the past year, while it has lost -95.48% so far this year.

Float and Shares Shorts:

At present, 53.30 million STAB shares are outstanding with a float of 44.59 million shares on hand for trading. On Oct 30, 2022, short shares totaled 2.29 million, which was 4.30% higher than short shares on Sep 29, 2022. In addition to Mr. Michael Kevin Handley as the firm’s CEO, Pres & Chairman, Mr. Christopher Zosh serves as its Exec. VP of Fin., Interim Principal Financial Officer & Interim Principal Accounting Officer.

Institutional Ownership:

Through their ownership of 5.41% of STAB’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 4.25% of STAB, in contrast to 1.30% held by mutual funds. Shares owned by individuals account for 0.11%. As the largest shareholder in STAB with 2.55% of the stake, Renaissance Technologies LLC holds 1,356,946 shares worth 1,356,946. A second-largest stockholder of STAB, The Vanguard Group, Inc., holds 378,677 shares, controlling over 0.71% of the firm’s shares. Northern Trust Investments, Inc. is the third largest shareholder in STAB, holding 171,110 shares or 0.32% stake. With a 0.71% stake in STAB, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 378,677 shares are owned by the mutual fund manager. The iShares Core S&P Total US Stock M, which owns about 0.20% of STAB stock, is the second-largest Mutual Fund holder. It holds 106,521 shares valued at 14913.0. SunAmerica Series Trust – SA T Ro holds 0.12% of the stake in STAB, owning 61,200 shares worth 8568.0.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Sep 29, 2022, STAB reported revenue of $0.00 and operating income of -$2.74M. The EBITDA in the recently reported quarter was -$2.61M and diluted EPS was -$0.07.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for STAB since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With STAB analysts setting a high price target of $40.00 and a low target of $40.00, the average target price over the next 12 months is $40.00. Based on these targets, STAB could surge 39900.0% to reach the target high and rise by 39900.0% to reach the target low. Reaching the average price target will result in a growth of 39900.0% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. STAB will report FY 2014 earnings on 02/20/2023. Analysts have provided yearly estimates in a range of -$3.20 being high and -$3.20 being low. For STAB, this leads to a yearly average estimate of -$3.20. Based on analyst estimates, the high estimate for the next quarter is -$1.00 and the low estimate is -$1.00. The average estimate for the next quarter is thus -$1.00.

Summary of Insider Activity:

Insiders traded STAB stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam